MHR
RGEN icon

Matthew Hamilton Rosenberg’s Repligen RGEN Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed -$566 – 957
2023
Q2 		$566 Hold
4
– – ﹤0.01% 832
2023
Q1 		$673 Hold
4
– – ﹤0.01% 855
2022
Q4 		$677 Sell
4
-1
-20% -$181 ﹤0.01% 846
2022
Q3 		$1K Buy
+5
New +$1.05K ﹤0.01% 831

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Matthew Hamilton Rosenberg's RGEN Position: Q3 2023 in Review

Matthew Hamilton Rosenberg sold out of Repligen (RGEN) in Q3 2023, closing a stake of 4 shares — an estimated $566 sold.

Matthew Hamilton Rosenberg first reported a position in RGEN in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Matthew Hamilton Rosenberg reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 4 Repligen shares in Q3 2023, an estimated $566.
  • Matthew Hamilton Rosenberg first reported a position in Repligen in Q3 2022 and held it in 4 quarters.
  • Matthew Hamilton Rosenberg's Repligen position peaked at $1K in Q3 2022.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2023, filed 11 Oct 2023.